You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

Article metrics

Article menu

Download PDFPDF

Rheumatoid arthritis
Original article
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 2020617605316
Jun 2020273258115
Jul 202016216031
Aug 2020928750
Sep 202010810453
Oct 202015014758
Nov 2020716241
Dec 2020868528
Jan 202110810558
Feb 202111110767
Mar 2021938946
Apr 2021706629
May 2021928558
Jun 2021726939
Jul 2021565331
Aug 2021656334
Sep 2021867954
Oct 2021595653
Nov 2021525042
Dec 2021514529
Jan 2022545036
Feb 2022858635
Mar 2022787440
Apr 2022827683
May 2022787457
Jun 2022666535
Jul 2022454516
Aug 2022545330
Sep 2022818037
Oct 2022767529
Nov 2022534727
Dec 2022534619
Jan 2023575626
Feb 2023757545
Mar 2023837754
Apr 2023465022
May 2023928838
Jun 2023595421
Jul 2023757541
Aug 2023474622
Sep 2023908327
Oct 2023867959
Nov 2023554617
Dec 2023413510
Jan 2024643717
Feb 2024332745
Mar 2024956596
Total427740392216